Get started
Author

Judit Börcsök

Observed names: Borcsok, Judit, Börcsök, Judit, J. Borcsok, Judit Borcsok, Judit Börcsok
ORCID: 0000-0002-3290-3971
Observed ORCID: 0000-0002-3290-3971
OpenAlex ID: A5012312294
Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations
2020 · Zsofia Sztupinszki, Miklos Diossy, et al. · Clinical Cancer Research · 101
Biologically informed deep learning for explainable epigenetic clocks
2024 · Aurel Prosz, Orsolya Pipek, et al. · Scientific Reports · 42
PDF
Comparative Assessment of Diagnostic Homologous Recombination Deficiency–Associated Mutational Signatures in Ovarian Cancer
2021 · Zsofia Sztupinszki, Miklos Diossy, et al. · Clinical Cancer Research · 37
PDF
RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics
2021 · Raie T. Bekele, Amruta S. Samant, et al. · Journal of Clinical Investigation · 36
PDF
Strand Orientation Bias Detector to determine the probability of FFPE sequencing artifacts
2021 · Miklos Diossy, Zsofia Sztupinszki, et al. · Briefings in Bioinformatics · 35
Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer
2020 · Judit Börcsök, Zsofia Sztupinszki, et al. · Clinical Cancer Research · 35
A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
2021 · Miklos Diossy, Zsofia Sztupinszki, et al. · npj Precision Oncology · 27
PDF
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer
2021 · Judit Börcsök, Miklos Diossy, et al. · Clinical Cancer Research · 26
PDF
ATM deficiency confers specific therapeutic vulnerabilities in bladder cancer
2023 · Yuzhen Zhou, Judit Börcsök, et al. · Science Advances · 24
PDF
Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human Cancers
2021 · Jintao Guo, Ying Zhou, et al. · Cancer Research · 13
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancer
2025 · Judit Börcsök, Diyavarshini Gopaul, et al. · Journal of Clinical Investigation · 11
PDF
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma
2023 · Aurel Prosz, Haohui Duan, et al. · Scientific Reports · 9
PDF
Hierarchy and control of ageing-related methylation networks
2021 · Gergely Palla, Péter Pollner, et al. · PLoS Computational Biology · 9
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting
2024 · Aurel Prosz, Pranshu Sahgal, et al. · npj Precision Oncology · 8
PDF
Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression
2024 · Miklos Diossy, Viktoria Tisza, et al. · npj Precision Oncology · 6
PDF
G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressor
2025 · Xin Li, Maria Rossing, et al. · JCI Insight · 3
Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumors
2025 · Zsofia Sztupinszki, Regina Fiam, et al. · npj Precision Oncology · 2
PDF
Subclonal CHD1 deletion is more frequent in African American prostate cancers and associated with rapid disease progression and limited levels of homologous recombination deficiency
2021 · Miklos Diossy, Viktoria Tisza, et al. · medRxiv · 2
PDF
The class II myosin MYH4 safeguards genome integrity and suppresses tumor progression
2025 · Jayashree Thatte, Ana Moisés da Silva, et al. · Journal of Clinical Investigation · 1
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting
2024 · Aurel Prosz, Pranshu Sahgal, et al. · npj Precision Oncology · 1
Metadata record for the article: A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
2021 · Diossy, Miklos, Sztupinszki, Zsofia, et al. · Figshare · 1
Prevalence of homologous recombination deficiency (HRD)-related signatures indicates that a wider range of prostate cancer patients may benefit from PARP-inhibitor therapy
2019 · Z. Sztupinszki, M. Diossy, et al. · Annals of Oncology · 1
PDF
Identification of an ERCC2 Mutation–Associated Mutational Signature of Nucleotide Excision Repair Deficiency in Targeted Panel Sequencing Data
2026 · Olivera Stojkova, Judit Börcsök, et al. · JCO Precision Oncology
PDF
Assessing expression patterns of PTGR1, a potential biomarker for acylfulven sensitivity in urothelial carcinoma
2024 · Dag Rune Stormoen, Signe Lehn, et al. · Scientific Reports
Supplementary Data from Detection of Molecular Signatures of Homologous Recombination Deficiency in Prostate Cancer with or without BRCA1/2 Mutations
2023 · Zsofia Sztupinszki, Miklos Diossy, et al.
PDF
Works count: 110
Citation count: 430
H-index: 11
I10-index: 11
Year
Topic
Type